Ciencias de la Salud

Permanent URI for this communityhttp://repositorio.uta.edu.ec/handle/123456789/813

Browse

Filters

20161

Settings

Author: search.filters.author.Dávila Taco, Víctor HugoSubject: search.filters.subject.NEUMONÍA

Search Results

Now showing 1 - 1 of 1
  • No Thumbnail Available
    Item
    Determinación de Agentes Patógenos Causantes de Neumonías y su Relación con Resistencia Bacteriana en la Unidad de cuidados Intensivos del Hospital Docente Ambato
    (Universidad Técnica de Ambato-Facultad de Ciencias de la Salud-Carrera Laboratorio Clínico, 2016-06-01) Dávila Taco, Víctor Hugo; Tabares Rosero, Lourdes Gioconda Dra.
    This research project's main objective is to determine pathogens causing pneumonia and its relation to bacterial resistance in the Intensive Care Unit of the Teaching Hospital Ambato. The study was conducted by laboratory tests which were the culture and sensitivity by the Kirby Bauer method which is able to verify the hypothesis. The study was conducted in 50 patients with pneumonia in the ICU, which revealed that 39.6% have the bacteria K. pneumoniae, S. pneumoniae has 37.5%, 14.6% presented S. aureus and 8.3% have P. aeruginosa. It is concluded that K. pneumoniae is resistant to Amoxicillin + ac . Clavulanate with 57.9 % , 47.4 % resistant to imipenem , resistant to Ciprofloxacin 42.1 % , 31.6 % resistant to Piperacillin / Tazobactam , resistant Cefaxitina 26.3% and 10.5% Cefepime and resistant cefotaxime , S. pneumoniae 44.4 % are resistant to clindamycin and imipenem , 38.9 % resistant to Amoxicillin + ac . clavulanic , resistant to cefotaxime 33.3% , 27.8 % resistant to levofloxacin , rifampin resistant 16.7 % and 11.1 % resistant to erythromycin and ceftriaxone , S. aureus 71 , 4 % is resistant to levofloxacin , Gentamicin resistant 57.1 % , 28.6 % resistant to Ciprofloxacin and clindamycin and 14.3 % resistant to Amoxicillin + ac . clavulanate and amikacin and P. aeruginosa 50% is resistant to Gentamicin , cefepime , ciprofloxacin and levofloxacin and 25% resistant to ceftazidime , imipenem and meropenem .